Skip to content
Thursday, November 12, 2026
Lumen Arena

The Zimbabwean Government Declines ‘One-Sided’ American Healthcare Assistance Agreement Due to Data Apprehensions

Medical funding image
The proposed American financial assistance was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a significant American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' insistence on confidential information.

This rejection came to light following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesman has since explained that the US was seeking health data for scientific study and commercial purposes while refused to guarantee the benefits from any future treatments.

"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has appealed for more talks to reach a deal suitable to all parties so the nation's critical HIV programme can continue.

Broader Background

This rejection follows a comparable case in Kenya, where a high court halted a related deal with the US after legal challenges were filed about the security of citizens' health data.

Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral agreements to enhance openness and accountability.

Based on reports, Sixteen African countries have so far signed similar agreements, representing over $18.3bn in new funding.

Specifics of the Rejected Deal

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation might have yielded significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana maintained the arrangement was "unfair".

"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"In essence, our country would supply the basic resources for scientific discovery without any certainty that the end products would be accessible to our citizens if a new health crisis emerge."

National Interest and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures previously set up via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage potential pandemics.

"This mechanism is intended to guarantee that when a nation contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We encourage ongoing discussions with our US partners on how future co-operation might be arranged in a way that respects the independence and interests of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that talks must proceed considering much of the country's HIV programmes relied on foreign aid.

"If specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group commented.

This impasse highlights the continuing tensions between accepting vital foreign assistance and protecting local interests in an ever more data-driven world.

CA
By

Christina Allen

A tech journalist and innovation strategist with over a decade of experience covering emerging technologies across Europe.

Lumen Arena

Type to search articles.